ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Could ePRO Be The New Standard In Health Reimbursement?

  Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.

• Data Quality And How It Impacts Clinical Trials

  Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.

• Fast, Focused Medical Data Review: Use Cases By A Medical Monitor

  See how the right data visualization tool can help medical monitors tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.

• 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies

  Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

• 3 Aspects To Consider When Selecting Your Next EDC Solution

  Not all electronic data collection systems are of the same quality or have the same key features. When selecting an EDC provider, keep these three aspects in mind.

• How To Prepare An IRB Submission For A Remote eConsent Study

  IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.

• How Digital Therapeutics Tools Interact To Improve Patient Care

  This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.

• Addressing The Challenges Of eCOA Licensing

  How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?

• Phase 4 Trials: A Critical Component Of Post-Marketing Insight

  Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

• Medable's Japanese Clinical Trial Exceeds FPI Date And eCOA Adherence

  A top-10 global pharma company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites in Japan. Explore an initiative to enhance the patient and site experience.